Jiang Yihang, Feng Sujuan, Ji Jiawei, Lin Zhemin, Zhang Xiaodong
Department of Urology, Beijing Chao-yang Hospital, Capital Medical University, NO. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing 100020, China.
Graduate School of Capital Medical University, NO. 10 You An Men Wai Xi Tou Tiao, Fengtai District, Beijing 100069, China.
Transpl Immunol. 2018 Jun;48:10-17. doi: 10.1016/j.trim.2018.02.007. Epub 2018 Feb 22.
Post-infectious immunosuppression is disadvantageous to patients' long-term outcomes, especially in transplant recipients receiving large doses of immunosuppressants. A growing body of evidence indicates the immunoregulatory ability of myeloid-derived suppressor cells (MDSCs). We herein investigate the characteristics of monocytic-MDSCs (M-MDSCs) in a cohort of renal transplant recipients with/without infection to clarify the potential involvement in post-infectious immunosuppression.
The study prospectively included 28 adult recipients who underwent allogeneic ABO-compatible renal transplant. Blood samples were drawn at day 0, 7, 14, 28, 60 and 90 postoperation. The incidence of infection and treatment strategies were recorded. The frequency and absolute number of peripheral blood M-MDSCs as well as other immune cells were determined by flow cytometry. Immnosuppressive functions of M-MDSCs were analyzed by inhibition of T cells proliferation. mRNA levels of immunosuppressive molecules in sorted M-MDSCs were also examined.
7 recipients were diagnosed with bacterial (n = 5) or viral (n = 2) infection and 3/5 of bacterial-infected recipients suffered from secondary infection during further follow-up. In the non-infected group, M-MDSCs numbers increased transiently during the early postoperative period, however, bacterial but not viral infection led to significant and persistent accumulation of M-MDSCs that remained at high levels after anti-infective treatments. M-MDSCs from infected recipients demonstrated potent ability to suppress T cells proliferation in vitro and negatively correlated with lymphocytes in vivo, yet not in the non-infected group. Inducible nitric oxide synthase (iNOS) mRNA levels were higher in sorted M-MDSCs when compared with monocytes, and suppressive activity was reversed by addition of a NOS inhibitor.
Circulating M-MDSCs underwent significant and persistent increases after bacterial infection in renal transplant recipients, contributing to post-infectious immunodeficiency. Therefore, special attention should be given to M-MDSCs during the monitoring of immune status and infection management.
感染后免疫抑制对患者的长期预后不利,尤其是在接受大剂量免疫抑制剂的移植受者中。越来越多的证据表明髓源性抑制细胞(MDSCs)具有免疫调节能力。我们在此研究一组有/无感染的肾移植受者中单核细胞源性MDSCs(M-MDSCs)的特征,以阐明其在感染后免疫抑制中的潜在作用。
本研究前瞻性纳入了28例接受ABO血型相容同种异体肾移植的成年受者。在术后第0、7、14、28、60和90天采集血样。记录感染发生率和治疗策略。通过流式细胞术测定外周血M-MDSCs以及其他免疫细胞的频率和绝对数量。通过抑制T细胞增殖分析M-MDSCs的免疫抑制功能。还检测了分选的M-MDSCs中免疫抑制分子的mRNA水平。
7例受者被诊断为细菌感染(n = 5)或病毒感染(n = 2),5例细菌感染的受者中有3例在进一步随访期间发生继发感染。在未感染组中,M-MDSCs数量在术后早期短暂增加,然而,细菌感染而非病毒感染导致M-MDSCs显著且持续积累,抗感染治疗后仍维持在高水平。来自感染受者的M-MDSCs在体外表现出强大的抑制T细胞增殖的能力,且在体内与淋巴细胞呈负相关,但在未感染组中无此现象。与单核细胞相比,分选的M-MDSCs中诱导型一氧化氮合酶(iNOS)mRNA水平更高,添加一氧化氮合酶抑制剂可逆转其抑制活性。
肾移植受者细菌感染后循环M-MDSCs显著且持续增加,导致感染后免疫缺陷。因此,在免疫状态监测和感染管理过程中应特别关注M-MDSCs。